Javed Yusuf Khatik

Title: Javed Yusuf Khatik: Innovator in TRPV Modulation

Introduction

Javed Yusuf Khatik is a notable inventor based in Thane, India. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that modulate TRPV3 receptors. With a total of 3 patents to his name, Khatik's work is paving the way for new therapeutic approaches.

Latest Patents

Khatik's latest patents include innovative compounds that serve as TRPV3 modulators. The first patent, titled "Chromane derivatives as TRPV3 modulators," presents chromane derivatives that are useful for treating or preventing diseases, conditions, and disorders modulated by TRPV3. This invention also details processes for preparing these compounds, intermediates used in their synthesis, and pharmaceutical compositions for treatment.

The second patent, "Fused pyrimidine derivatives as TRPV3 modulators," focuses on fused pyrimidine derivatives that are beneficial for treating diseases and conditions modulated by TRPV3. This invention includes a specific formula and its pharmaceutically acceptable salts, along with the processes for their synthesis.

Career Highlights

Throughout his career, Khatik has worked with reputable companies, including Glenmark Pharmaceuticals S.A. His experience in the pharmaceutical industry has equipped him with the knowledge and skills necessary to innovate in the field of drug development.

Collaborations

Khatik has collaborated with notable professionals such as Abraham Thomas and Neelima Khairatkar-Joshi. These collaborations have likely contributed to the success of his inventions and the advancement of research in TRPV modulation.

Conclusion

Javed Yusuf Khatik is a distinguished inventor whose work in TRPV3 modulation is making a significant impact in the pharmaceutical industry. His innovative patents and collaborations highlight his commitment to advancing medical science.